Human Molecular Genetics, 2000, Vol. 9, No. 20 3055-3064
© 2000 Oxford University Press
Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations
1Medical and Molecular Genetics Center-IRO, Hospital Duran i Reynals, Autovia de Castelldefels km 2.7 08907 LHospitalet de Llobregat, Barcelona, Spain, 2Department of Neuropediatrics, Heinrich-Heine-University, Childrens Hospital, Moorenstrasse 5, 40225 Düsseldorf, Germany and 3Department of Biochemistry, School of Health Sciences, International University of Catalonia, Sant Cugat del Vallès, Barcelona, Spain
Neurofibromas are one of the most characteristic features of neurofibromatosis type 1 (NF1), an inherited autosomal-dominant neurogenetic disorder affecting 1 in 3500 individuals worldwide. These benign tumors mainly consist of Schwann cells (SCs) and fibroblasts. Recent evidence demonstrates that somatic mutations at the NF1 gene are found in neurofibromas, but it has not been demonstrated whether SCs, fibroblasts and/or both cell types bear a somatic loss of NF1. We recently established a cell culture system that allows selective expansion of human SCs from neurofibromas. We cultured pure populations of SCs and fibroblasts derived from 10 neurofibromas with characterized NF1 mutations and found that SCs but not fibroblasts harbored a somatic mutation at the NF1 locus in all studied tumors. Furthermore, by culturing neurofibroma-derived SCs under different in vitro conditions we were able to obtain two genetically distinct SC subpopulations: NF1/ and NF1+/. These data strongly support the idea that NF1 mutations in SCs, but not in fibroblasts, correlate to neurofibroma formation and demonstrate that only a portion of SCs in neurofibromas have mutations in both NF1 alleles.
+ These authors contributed equally to this work
§ To whom correspondence should be addressed. Tel: +34 93 260 7775; Fax: +34 93 260 7776; Email: clazaro@iro.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Lavery, V. Hall, J. C. Yager, A. Rottgers, M. C. Wells, and M. Stern Phosphatidylinositol 3-Kinase and Akt Nonautonomously Promote Perineurial Glial Growth in Drosophila Peripheral Nerves J. Neurosci., January 10, 2007; 27(2): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Yang, S. Chen, T. Clegg, X. Li, T. Morgan, S. A. Estwick, J. Yuan, W. Khalaf, S. Burgin, J. Travers, et al. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-{beta} signaling Hum. Mol. Genet., August 15, 2006; 15(16): 2421 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Theos and B. R. Korf Pathophysiology of neurofibromatosis type 1. Ann Intern Med, June 6, 2006; 144(11): 842 - 849. [Full Text] [PDF] |
||||
![]() |
K. M. Reilly, K. W. Broman, R. T. Bronson, S. Tsang, D. A. Loisel, E. S. Christy, Z. Sun, J. Diehl, D. J. Munroe, and R. G. Tuskan An Imprinted Locus Epistatically Influences Nstr1 and Nstr2 to Control Resistance to Nerve Sheath Tumors in a Neurofibromatosis Type 1 Mouse Model Cancer Res., January 1, 2006; 66(1): 62 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Johannessen, E. E. Reczek, M. F. James, H. Brems, E. Legius, and K. Cichowski The NF1 tumor suppressor critically regulates TSC2 and mTOR PNAS, June 14, 2005; 102(24): 8573 - 8578. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kirschner, D. F. Kusewitt, L. Matyakhina, W. H. Towns II, J. A. Carney, H. Westphal, and C. A. Stratakis A Mouse Model for the Carney Complex Tumor Syndrome Develops Neoplasia in Cyclic AMP-Responsive Tissues Cancer Res., June 1, 2005; 65(11): 4506 - 4514. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Joseph, Y.-s. Mukouyama, J. T. Mosher, M. Jaegle, S. A. Crone, E.-L. Dormand, K.-F. Lee, D. Meijer, D. J. Anderson, and S. J. Morrison Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells Development, November 15, 2004; 131(22): 5599 - 5612. [Abstract] [Full Text] [PDF] |
||||
![]() |
R E Ferner, R A C Hughes, S M Hall, M Upadhyaya, and M R Johnson Neurofibromatous neuropathy in neurofibromatosis 1 (NF1) J. Med. Genet., November 1, 2004; 41(11): 837 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Levy, I. Bieche, K. Leroy, B. Parfait, J. Wechsler, I. Laurendeau, P. Wolkenstein, M. Vidaud, and D. Vidaud Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Identification of a Gene Expression Signature of Poor Prognosis Clin. Cancer Res., June 1, 2004; 10(11): 3763 - 3771. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Krammer, K. Wimmer, P. Wiesbauer, M. Rasse, S. Lang, A. Mullner-Eidenbock, and H. Frisch Neurofibromatosis 1: A Novel NF1 Mutation in an 11-Year-Old Girl With a Giant Cell Granuloma J Child Neurol, May 1, 2003; 18(5): 371 - 373. [Abstract] [PDF] |
||||
![]() |
S. J. Miller, H. Li, T. A. Rizvi, Y. Huang, G. Johansson, J. Bowersock, A. Sidani, J. Vitullo, K. Vogel, L. M. Parysek, et al. Brain Lipid Binding Protein in Axon-Schwann Cell Interactions and Peripheral Nerve Tumorigenesis Mol. Cell. Biol., March 15, 2003; 23(6): 2213 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. McLaughlin and T. Jacks Progesterone Receptor Expression in Neurofibromas Cancer Res., February 15, 2003; 63(4): 752 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Korf Review Article : Clinical Features and Pathobiology of Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 573 - 577. [Abstract] [PDF] |
||||
![]() |
A. Kurtz and R. L. Martuza Review Article : Antiangiogenesis in Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 578 - 584. [Abstract] [PDF] |
||||
![]() |
H. Li, S. Velasco-Miguel, W. C. Vass, L. F. Parada, and J. E. DeClue Epidermal Growth Factor Receptor Signaling Pathways Are Associated with Tumorigenesis in the Nf1:p53 Mouse Tumor Model Cancer Res., August 1, 2002; 62(15): 4507 - 4513. [Abstract] [Full Text] [PDF] |
||||
![]() |
L De Smet, R Sciot, and E Legius Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1 J. Med. Genet., August 1, 2002; 39(8): e45 - 45. [Full Text] [PDF] |
||||
![]() |
Plexiform neurofibromas in NF1: Toward biologic-based therapy Neurology, May 28, 2002; 58(10): 1461 - 1470. |
||||
![]() |
Y. Zhu, P. Ghosh, P. Charnay, D. K. Burns, and L. F. Parada Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment Science, May 3, 2002; 296(5569): 920 - 922. [Abstract] [Full Text] [PDF] |
||||











